Molecular Epidemiology of HIV-1 in African Countries: A Comprehensive Overview

The human immunodeficiency virus type 1 (HIV-1) originated in non-human primates in West-central Africa and continues to be a major global public health issue, having claimed almost 33 million lives so far. In Africa, it is estimated that more than 20 million people are living with HIV/Acquired Immunodeficiency Syndrome (AIDS) and that more than 730,000 new HIV-1 infections still occur each year, likely due to low access to testing. The high genetic variability of HIV-1, due to a fast replication cycle and high mutation rate, may cause the generation of many viral variants in a single infected patient during a single day. Therefore, the active monitoring and characterization of the HIV-1 subtypes and recombinant forms circulating through African countries poses a significant challenge to more specific diagnoses, treatments, care, and intervention strategies. In this review, a concise characterization of all the subtypes and recombinant forms circulating in Africa is presented to highlight the magnitude of the HIV-1 threat among the African countries and to understand virus genetic diversity and dispersion dynamics better.

[1]  J. Hemelaar,et al.  Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015 , 2020, Journal of virology.

[2]  H. Xing,et al.  Near Full-Length Genomic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF106_cpx) Identifified among Heterosexuals in China. , 2020, AIDS research and human retroviruses.

[3]  M. Churchill,et al.  Understanding the mechanisms driving the spread of subtype C HIV-1 , 2020, EBioMedicine.

[4]  L. Makola,et al.  HIV prevalence in South Africa through gender and racial lenses: results from the 2012 population-based national household survey , 2019, International Journal for Equity in Health.

[5]  B. Foley,et al.  Characterization of HIV-1 subtypes among South Sudanese patients. , 2019, AIDS research and human retroviruses.

[6]  P. Kaleebu,et al.  HIV subtype diversity worldwide , 2019, Current opinion in HIV and AIDS.

[7]  M. Gebregziabher,et al.  Gender Disparities in Receipt of HIV Testing Results in Six Sub-Saharan African Countries , 2018, Health equity.

[8]  L. Cerutti,et al.  Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification , 2018, Retrovirology.

[9]  M. Soroush,et al.  HIV/AIDS in the Middle East and North Africa: a positive future , 2018, Sexually Transmitted Infections.

[10]  E. van Doorslaer,et al.  The rise and fall of mortality inequality in South Africa in the HIV era , 2018, SSM - population health.

[11]  B. Maughan-Brown,et al.  HIV Risk Among Adolescent Girls and Young Women in Age-Disparate Partnerships: Evidence From KwaZulu-Natal, South Africa , 2018, Journal of acquired immune deficiency syndromes.

[12]  A. Rodrigues,et al.  HIV-2 continues to decrease, whereas HIV-1 is stabilizing in Guinea-Bissau , 2018, AIDS.

[13]  B. Korber,et al.  Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection , 2018, Nature Communications.

[14]  Lei Zhang,et al.  HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, China , 2017, Scientific Reports.

[15]  G. Magiorkinis,et al.  The application of HIV molecular epidemiology to public health. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[16]  C. Charpentier,et al.  Hiv-2 molecular epidemiology. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  C. Morrison,et al.  Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa , 2016, EBioMedicine.

[18]  Qiyun Shi,et al.  Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses , 2016, BMJ Open.

[19]  Robert Koch-Institut,et al.  Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study , 2016, The Lancet. Infectious diseases.

[20]  C. Fraser,et al.  PANGEA-HIV: phylogenetics for generalised epidemics in Africa. , 2015, Lancet. Infectious Diseases (Print).

[21]  M. Suchard,et al.  The early spread and epidemic ignition of HIV-1 in human populations , 2014, Science.

[22]  Jing-yun Li,et al.  Recombination Pattern Reanalysis of Some HIV-1 Circulating Recombination Forms Suggest the Necessity and Difficulty of Revision , 2014, PloS one.

[23]  M. Weiss,et al.  HIV in the Middle East and North Africa: priority, culture, and control , 2013, International Journal of Public Health.

[24]  Andrew J. Tatem,et al.  Spatial accessibility and the spread of HIV-1 subtypes and recombinants , 2012, AIDS.

[25]  A. Abimiku,et al.  Update on HIV-1 diversity in Africa: a decade in review. , 2012, AIDS reviews.

[26]  J. Hemelaar,et al.  The origin and diversity of the HIV-1 pandemic. , 2012, Trends in molecular medicine.

[27]  P. Sharp,et al.  Origins of HIV and the AIDS pandemic. , 2011, Cold Spring Harbor perspectives in medicine.

[28]  P. Kaleebu,et al.  Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda , 2011, Virology.

[29]  C. Brennan,et al.  Confirmation of Putative HIV-1 Group P in Cameroon , 2010, Journal of Virology.

[30]  S. Hammer,et al.  The challenge of HIV-1 subtype diversity. , 2008, The New England journal of medicine.

[31]  F. Buonaguro,et al.  Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications , 2007, Journal of Virology.

[32]  C. Gray,et al.  Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. , 2004, The Journal of infectious diseases.

[33]  B. Korber,et al.  Evolutionary and immunological implications of contemporary HIV-1 variation. , 2001, British medical bulletin.

[34]  B T Foley,et al.  Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. , 2001, AIDS research and human retroviruses.

[35]  Martine Peeters,et al.  Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa , 2000, Journal of Virology.

[36]  M. Salminen,et al.  Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. , 2000, AIDS research and human retroviruses.

[37]  G. Learn,et al.  HIV-1 Nomenclature Proposal , 2000, Science.

[38]  P. Sharp,et al.  AIDS as a zoonosis: scientific and public health implications. , 2000, Science.

[39]  M. Peeters,et al.  Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. , 2000, AIDS research and human retroviruses.

[40]  F. Gao,et al.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes , 1999, Nature.

[41]  F. McCutchan,et al.  A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. , 1998, AIDS research and human retroviruses.

[42]  F. Brun-Vézinet,et al.  Identification of a new human immunodeficiency virus type 1 distinct from group M and group O , 1998, Nature Medicine.

[43]  L. M. Mansky,et al.  Retrovirus mutation rates and their role in genetic variation. , 1998, The Journal of general virology.

[44]  P. Sharp,et al.  Recombination in HIV-1 , 1995, Nature.

[45]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[46]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[47]  J Leibowitch,et al.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). , 1983, Science.

[48]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[49]  C. McArthur,et al.  Complete genome sequence of CG-0018 a-01 establishes HIV-1 subtype L , 2019 .

[50]  M. Lederman,et al.  Origins of HIV and the AIDS Pandemic , 2011 .

[51]  Jennifer M. Hentz The Impact of HIV on the Rape Crisis in the African Great Lakes Region , 2005 .

[52]  F. McCutchan,et al.  Understanding the genetic diversity of HIV-1. , 2000, AIDS.

[53]  J. Goudsmit,et al.  HIV heterogeneity and disease progression in AIDS: a model of continuous virus adaptation. , 1998, AIDS.